SCHEMBL7703099

SCHEMBL7703099

N#Cc1cccc(C(=O)CC(=O)Nc2cc(I)c(N3CCOCC3)cc2NC(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.49
HTT P42858 1/20 0.42
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
SCN9A Q15858 1/20 0.41
ALDH1A1 P00352 8/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CNR1 P21554 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.40
AKT1 P31749 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CASR P41180 1/20 0.39
NTRK1 P04629 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144967 0.88 RXFP1 (0.47) RXFP1HTTKMT2ANPC1ALDH1A1
SCHEMBL6433015 0.78 RXFP1 (0.46) RXFP1HTTKMT2ANPC1ALDH1A1
SCHEMBL7141582 0.78 RORC (0.38) RXFP1
SCHEMBL7143603 0.77 RXFP1 (0.43) RXFP1HTTKMT2ANPC1ALDH1A1
SCHEMBL7704508 0.73 GPR6 (0.38) RXFP1ALDH1A1SMN1; SMN2
SCHEMBL7463263 0.73 GPR139 (0.45) KMT2AALDH1A1CNR1LMNA
SCHEMBL7459390 0.72 GSK3B (0.46) KMT2ALMNA
SCHEMBL7046359 0.71 KDM4E (0.44) KMT2AALDH1A1SMN1; SMN2LMNANPSR1
SCHEMBL7700583 0.70 GSK3B (0.43) KMT2ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL6434557 0.70 MAPT (0.40) RXFP1HTTKMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed